PräVaNet - Structured, Intersectoral, Multiprofessional, Digitized Program to Optimize Cardiovascular Prevention

Inclusion Criteria

• •Included are patients who at baseline:
• •Are at least 18 years or older
• •Living in the German federal states of Berlin or Brandenburg
• •Insured by the cooperating German SHI company
• •Diagnosed with type 2 diabetes mellitus at least 3 months prior to study entry and who
• •Require drug therapy for diabetes mellitus type 2; i.e., received at least 1 oral antidiabetic drug or insulin therapy for at least 3 months prior to study entry; such a need for drug therapy should also exist at the start of the study for the next year and beyond
• •and
• •Fulfill at least one of the following criteria:
• •1. metabolic syndrome: 3 of the following 4 criteria: Waist-to-hip ratio (WHR) \> 94 cm/80 cm; triglycerides ≥ 150 md/dl or cholesterol- or lipid-lowering therapy; high density lipoprotein (HDL) \< 40/50 mg/dl or cholesterol- or lipid-lowering therapy; hypertension ≥ 135/85 mmHg or antihypertensive therapy;
• •and/or
• •2. macrovascular manifestations (coronary artery disease (CAD) and/or peripheral arterial disease (CAD) and/or carotid stenosis)
• •and/or
• •3. microvascular manifestation (chronic renal failure with estimated glomerular filtration rate (eGFR) \< 60ml/min/1.73m2).